Preclinical Strategies to Identify Off-Target Toxicity of High-Affinity TCRs.

about

Preclinical Strategies to Identify Off-Target Toxicity of High-Affinity TCRs.

Item

http://www.wikidata.org/entity/Q54250628

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Preclinical Strategies to Identify Off-Target Toxicity of High-Affinity TCRs.

@en

Preclinical Strategies to Identify Off-Target Toxicity of High-Affinity TCRs.

@nl

type

Item

label

Preclinical Strategies to Identify Off-Target Toxicity of High-Affinity TCRs.

@en

Preclinical Strategies to Identify Off-Target Toxicity of High-Affinity TCRs.

@nl

prefLabel

Preclinical Strategies to Identify Off-Target Toxicity of High-Affinity TCRs.

@en

Preclinical Strategies to Identify Off-Target Toxicity of High-Affinity TCRs.

@nl

P1476

Preclinical Strategies to Identify Off-Target Toxicity of High-Affinity TCRs

@en

P2093

Anne K Wouters

http://www.w3.org/2001/XMLSchema#string

Dirk M van der Steen

http://www.w3.org/2001/XMLSchema#string

Helena M Bijen

http://www.w3.org/2001/XMLSchema#string

J H Frederik Falkenburg

http://www.w3.org/2001/XMLSchema#string

Linda Wooldridge

http://www.w3.org/2001/XMLSchema#string

Renate S Hagedoorn

http://www.w3.org/2001/XMLSchema#string

P2860

Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen

Cross-Reactivity of TCR Repertoire: Current Concepts, Challenges, and Implication for Allotransplantation

TCR affinity for p/MHC formed by tumor antigens that are self-proteins: impact on efficacy and toxicity

Inducible apoptosis as a safety switch for adoptive cell therapy

Re-adapting T cells for cancer therapy: from mouse models to clinical trials.

NY-ESO-1-specific TCR-engineered T cells mediate sustained antigen-specific antitumor effects in myeloma.

Hematopoiesis-restricted minor histocompatibility antigens HA-1- or HA-2-specific T cells can induce complete remissions of relapsed leukemia

Negative selection--clearing out the bad apples from the T-cell repertoire.

A pilot trial using lymphocytes genetically engineered with an NY-ESO-1-reactive T-cell receptor: long-term follow-up and correlates with response

A single autoimmune T cell receptor recognizes more than a million different peptides.

P304

1206-1214

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.YMTHE.2018.02.017

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Mirjam H.M. Heemskerk

P577

2018-02-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29567312

http://www.w3.org/2001/XMLSchema#string

P932

5993934

http://www.w3.org/2001/XMLSchema#string